Barco Healthcare is continually looking for ways to streamline radiology workflow and support the best patient care. We are proud that with SpotView and Coronis Uniti we can help healthcare professionals to achieve both, with proven enhancements to workflow and the possibility to reduce mammographic radiation dose without impacting diagnostic accuracy.
2018年7月5日
Barco to highlight advanced imaging tool, breast imaging display solutions at IWBI 2018
SpotView™ is proven to increase reading accuracy and reduce reading time
Atlanta, GA – July 05, 2018 – Barco, the leader in global healthcare imaging, will exhibit its advanced imaging tool SpotView, in addition to the Coronis Uniti® 12MP and Nio Color 5.8MP display systems, at the International Workshop on Breast Imaging (IWBI) in Atlanta, July 9-11.
Study proves that it is possible to reduce mammographic dose without impacting diagnostic accuracy
A recent study by Elizabeth A. Krupinski, PhD, FSIIM, Professor, Radiology & Imaging Sciences, at Emory University, found that with SpotView and I-Luminate™ it is possible to reduce mammographic dose without impacting diagnostic accuracy. The paper, “Reducing Radiation Dose in Digital Mammography by Increasing Display Luminance,” also highlights that SpotView can increase reading accuracy by 6% and reduce reading times by 16%.The study, largely performed on Barco’s Coronis Uniti display, points to the overwhelming clinical advantages of SpotView.
High-bright color display improves diagnoses and workflow
Barco's Nio Color 5MP renders excellent color and grayscale breast images. Its high brightness (500 cd/m2), high contrast ratio and calibrated color help users discern the most subtle image details for an accurate diagnosis. And the additional resolution allows users to fit more of the image on the screen for reduced panning and zooming.
Barco to present at IWBI, Tuesday, July 10
Barco continues to focus on clinical research and development around improving breast cancer detection for better patient outcomes. At IWBI, Barco will present research on the detection of clinically relevant spiculated breast masses in a study titled “An Anthropomorphic Model Observer for Spiculated Masses” presented by Ali Avanaki, Senior Research Engineer for Barco Healthcare.
About Barco
Barco designs technology to enable bright outcomes around the world. Seeing beyond the image, we develop visualization and collaboration solutions to help you work together, share insights, and wow audiences. Our focus is on three core markets: Enterprise (from meeting and control rooms to corporate spaces), Healthcare (from the radiology department to the operating room), and Entertainment (from movie theaters to live events and attractions). In 2017, we realized sales of 1.085 billion euro. We have a team of 3,600 employees, located in 90 countries, whose passion for technology is captured in 400 granted patents.
For more information, visit us on www.barco.com, follow us on Twitter (@Barco), LinkedIn (Barco), YouTube (BarcoTV), or like us on Facebook (Barco).
© Copyright 2018
接收最新的服务和产品新闻
点击"注册", you agree to receive the communication requested in above form. You can read our privacy policy here. You can unsubscribe at any time. This site is protected by Cloudflare Turnstile. The Cloudflare Privacy Policy and Cloudflare Terms of Use apply.
谢谢！
现在请检查您的收件箱并确认订阅！